---
schema_version: "secwatch.filing_event.v1"
accession: "0001562762-25-000114"
form_type: "8-K"
ticker: "GMED"
cik: "0001237831"
company_name: "GLOBUS MEDICAL INC"
filed_at: "2025-05-08T23:59:59+00:00"
generated_at: "2026-05-22T03:19:42.856207+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Globus Medical Q1 revenue down 1.4% to $598.1M; cuts non-GAAP EPS guidance to $3.00-$3.30

## Summary
- GAAP net income $75.5M; GAAP diluted EPS $0.54 vs ($0.05) a year ago.
- Non-GAAP diluted EPS $0.68, up 8.5% YoY; prior guidance $3.10-$3.40 now $3.00-$3.30.
- Revenue fell 1.4% as-reported (0.8% constant currency); US up 0.2%, Intl down 7.7% as-reported.
- Paid off remaining $450M debt from NuVasive merger; Q1 free cash flow $141.2M.
- Company cites softer Enabling Technology deals, supply chain disruption, and timing of intl orders.

## SEC filing metadata
- accession: 0001562762-25-000114
- form_type: 8-K
- ticker: GMED
- cik: 0001237831
- company_name: GLOBUS MEDICAL INC
- filed_at: 2025-05-08T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1237831/000156276225000114/0001562762-25-000114-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1237831/000156276225000114/gmed-20250508x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001562762-25-000114
- JSON: https://secwatch.observer/filing/0001562762-25-000114.json
- Plain text: https://secwatch.observer/filing/0001562762-25-000114.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.